Identification of genes induced by carbamazepine in human bronchial epithelial BEAS-2B cells

Toxicology and Environmental Health Sciences

Volumn 3, Issue 2, 2011, Pages 106-113

  Song, Mee ^a   Kim, Youn Jung ^b   Ryu, Jae Chun ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Carbamazepine (CBZ); Gene ontology (GO); Microarray; Pulmonary toxicity

Indexed keywords

CARBAMAZEPINE; MESSENGER RNA; OLIGONUCLEOTIDE;

ARTICLE; BRONCHUS MUCOSA; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL VIABILITY; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; EPITHELIUM CELL; EXPOSURE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LUNG TOXICITY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84856271992     PISSN: 20059752     EISSN: 22337784     Source Type: Journal    
DOI: 10.1007/s13530-011-0085-2     Document Type: Article

References (32)

1. Archibald, N. et al. Carbamazepine-induced interstitial pneumonitis in a lung transplant patient. Respir. Med. 100, 1660-1662 (2006).
2. Wilschut, F. A. et al. Recurrent respiratory distress associated with carbamazepine overdose. Eur. Respir. J. 10, 2163-2165 (1997).
3. Ozkan, M., Dweik, R. A. & Ahmad, M. Drug-induced lung disease. Cleve. Clin. J. Med. 68, 782-785, 789-795 (2001).
4. Zhang, W., Ding, Y., Boyd, S. A., Teppen, B. J. & Li, H. Sorption and desorption of carbamazepine from water by smectite clays. Chemosphere. 81, 954-960 (2010).
5. Thacker, P. D. Pharmaceutical data elude researchers. Environ. Sci. Technol. 39, 193A-194A (2005).
6. Lienert, J., Güdel, K. & Escher, B. I. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ. Sci. Technol. 41, 4471-4478 (2007).
7. Zhang, Y., Geissen, S. U. & Gal, C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere. 73, 1151-1161 (2008).
8. Carballa, M., Omil, F. & Lema, J. M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere. 72, 1118-1123 (2008).
9. Sim, W. J., Lee, J. W. & Oh, J. E. Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea. Environ. Pollut. 158, 1938-1947 (2010).
10. Tixier, C., Singer, H. P., Oellers, S. & Müller, S. R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 37, 1061-1068 (2003).
11. Löffler, D., Römbke, J., Meller, M. & Ternes, T. A. Environmental fate of pharmaceuticals in water/sediment systems. Environ. Sci. Technol. 39, 5209-5218 (2005).
12. Chenxi, W., Spongberg, A. L. & Witter, J. D. Determination of the persistence of pharmaceuticals in biosolids using liquid-chromatography tandem mass spectrometry. Chemosphere. 73, 511-518 (2008).
13. Ferrari, B., Paxéus, N., Lo Giudice, R., Pollio, A. & Garric, J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Saf. 55, 359-370 (2003).
14. 2 nanoparticles. Mol. Cell. Toxicol. 6, 97-104 (2010).
15. Oscarson, M. et al. Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin. Pharmacol. Ther. 80, 440-456 (2006).
16. Seo, T. et al. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics. 7, 551-561 (2006).
17. Mann, L. et al. Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect. Bipolar Disord. 11, 885-896 (2009).
18. Oscarson, M. et al. Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin. Pharmacol. Ther. 80, 440-456 (2006).
19. Hung, S. I. et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet. Genomics. 16, 297-306 (2006).
20. Ghelardoni, S., Tomita, Y. A., Bell, J. M., Rapoport, S. I. & Bosetti, F. Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol. Psychiatry. 56, 248-254 (2004).
21. Kim, W. J. et al. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet. Genomics. 20, 249-256 (2010).
22. Meng, Q. W. et al. Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells. Ai Zheng. 25, 967-973 (2006).
23. Makmor-Bakry, M. et al. Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing. Clin. Neuropharmacol. 32, 205-212 (2009).
24. Pirmohamed, M., Lin, K., Chadwick, D. & Park, B. K. TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients. Neurology. 56, 890-896 (2001).
25. Alfirevic, A. et al. Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster. Pharmacogenet. Genomics. 16, 287-296 (2006).
26. Lu, W., Li, X. & Uetrecht, J. P. Changes in gene expression induced by carbamazepine and phenytoin: testing the danger hypothesis. J. Immunotoxicol. 5, 107-113 (2008).
27. Delvecchio, C. J., Bilan, P., Nair, P. & Capone, J. P. LXR-induced reverse cholesterol transport in human airway smooth muscle is mediated exclusively by ABCA1. Am. J. Physiol. Lung Cell Mol. Physiol. 295, L949-957 (2008).
28. Pie, J. E. et al. Correlation between nutrition intake and gene expression profiles in children with asthma. Mol. Cell. Toxicol. 6, 313-319 (2010).
29. Song, M., Kim, Y. J. & Ryu, J. C. Phospholipidosis induced by PPARγ signaling in human bronchial epithelial (BEAS-2B) cells exposed to amiodarone. Toxicol. Sci. 120, 98-108 (2011).
30. Leite, S. A., Leite, P. J., Rocha, G. A., Routledge, P. A. & Bittencourt, P. R. Carbamazepine kinetics in cardiac patients before and during amiodarone. Arq. Neuropsiquiatr. 52, 210-215 (1994).
31. Vancheri, C., Failla, M., Crimi, N. & Raghu, G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur. Respir. J. 35, 496-504 (2010).
32. Song, M., Kim, Y. J. & Ryu, J. C. Induction of ROS, p38 MAP Kinase and apoptosis via pulmonary toxic drugs. BioChip J. 3, 306-315 (2009).